Is there any reason to withhold alpha2 agonists from patients with coronary disease during surgery?
Quintin
Luc
L
Ghignone
Marco
M
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003327:Coronary Disease / Q000150:complications* / Q000601:surgery*; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists